Investigation of the Detection Rate of Pathogenic Viruses in the Feces of Individuals With Non-gastrointestinal Infections
NCT ID: NCT06367647
Last Updated: 2024-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2024-05-04
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
NCT06524791
FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis
NCT06206707
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
NCT05714566
Stool Transplant to Control Treatment-related Diarrhea
NCT04883762
SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.
NCT05567419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
apparently healthy individuals
No interventions assigned to this group
parenteral virus infected patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. no obvious symptoms and signs of the disease;
3. not taking a drug for a long time;
4. good psychological condition ;
5. no unhealthy lifestyle;
6. willing to participate in the study, sign the informed consent, fill out the questionnaire and provide fecal samples.
Exclusion Criteria
2. suffering from certain diseases, such as cardiovascular disease, digestive system disease and nervous system disease.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhujiang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yan He
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan He, Doctor
Role: PRINCIPAL_INVESTIGATOR
Southern Medical University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhujiang hospital of southern medical university
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
zhujiangjy-20240229
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.